Health care costs of heart failure:: results from a randomised study of patient education

被引:30
作者
Linné, AB [1 ]
Liedholm, H
Jendteg, S
Israelsson, B
机构
[1] Malmo Univ Hosp, MFC, Dept Community Med, S-20502 Malmo, Sweden
[2] Swedish Inst Hlth Econ, Lund, Sweden
[3] Univ Lund, Malmo Univ Hosp, Dept Cardiol, Lund, Sweden
关键词
heart failure; health care costs; individual patients;
D O I
10.1016/S1388-9842(00)00089-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Heart failure is a serious syndrome with a bad prognosis. Hospitalisation is common and readmittance rate is high; factors which influence the cost of care and treatment. Only scarce data on detailed patient materials regarding health care costs are known. Aims: To describe in detail the health care costs for heart failure patients. Methods: Costs for patients (n = 108) who completed a randomised education trial were studied for 6 months after hospital discharge. Costs for hospital stay, out-patient visits, diagnostic tests and procedures, laboratory analyses and drug treatment were calculated. Official unit prices list used to reimburse providers of cross-boundary health services and prices for drugs in the Swedish Drug Compendium were employed. Results: The total cost for a heart failure patient was approximately 20 000 SEK (2564 US$, 7.80 SEK = 1 US$) for 6 months. There was a 27-fold variation between patients. There was no relation between age or sex and cost. In decreasing order cost for hospitalisation was followed by costs for out-patient visits, diagnostic tests and procedures, laboratory analyses and drugs. Conclusion: Hospitalisation was the largest part of the total cost and there was a large inter-individual variation. Efforts to reduce the economic burden should be focused on hospitalisation. Due to skewed distribution, individual data must be considered in the analysis of the efforts. (C) 2000 European Society of Cardiology. All rights reserved.
引用
收藏
页码:291 / 297
页数:7
相关论文
共 12 条
[1]   Cost effective management programme for heart failure reduces hospitalisation [J].
Cline, CMJ ;
Israelsson, BYA ;
Willenheimer, RB ;
Broms, K ;
Erhardt, LR .
HEART, 1998, 80 (05) :442-446
[2]   HOSPITAL READMISSIONS AMONG THE ELDERLY [J].
GOODING, J ;
JETTE, AM .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1985, 33 (09) :595-601
[3]  
Lechat P, 1999, LANCET, V353, P9
[4]   Effects of systematic education on heart failure patients' knowledge after 6 months.: A randomised, controlled trial [J].
Linné, AB ;
Liedholm, H ;
Israelsson, B .
EUROPEAN JOURNAL OF HEART FAILURE, 1999, 1 (03) :219-227
[5]   The pharmacoeconomics of ACE inhibitors in chronic heart failure [J].
McMurray, J ;
Davie, A .
PHARMACOECONOMICS, 1996, 9 (03) :188-197
[6]  
Packer M, 1999, AM J CARDIOL, V83, p1A
[7]   Cost-effective management of heart failure [J].
Parmley, WW .
CLINICAL CARDIOLOGY, 1996, 19 (03) :240-242
[8]   Cost-effectiveness analysis in clinical practice - The case of heart failure [J].
Rich, MW ;
Nease, RF .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (15) :1690-1700
[9]   A MULTIDISCIPLINARY INTERVENTION TO PREVENT THE READMISSION OF ELDERLY PATIENTS WITH CONGESTIVE-HEART-FAILURE [J].
RICH, MW ;
BECKHAM, V ;
WITTENBERG, C ;
LEVEN, CL ;
FREEDLAND, KE ;
CARNEY, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (18) :1190-1195
[10]   The health care costs of heart failure in Sweden [J].
Rydén-Bergsten, T ;
Andersson, F .
JOURNAL OF INTERNAL MEDICINE, 1999, 246 (03) :275-284